The discovery and development of a CRISPR/Cas9-engineered tumor-infiltrating lymphocytes product (GT316) as a next-generation TIL therapyYarong Liu,Jingwei Sun,Yao Sheng,Jingman Wang,Jiahui Jin,Fei Li,Lingyun Chen,Di Zhou,Yongchao Tan, Quanwei Wang, Zhao Xu,Haibao Li,Pin Wang,Jun CuiCANCER RESEARCH(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要